Study on the Effect of Pogostemon Cablin Benth on Skin Aging Based on Network Pharmacology

Author:

Pan Liming1ORCID,Wu Jiting1ORCID

Affiliation:

1. College of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangdong, China

Abstract

Background: There is still little research on the anti-aging effect of Pogostemon cablin Benth (PCB) on human skin. In this paper, the mechanism of the anti-aging effect of PCB on human skin was studied by using network pharmacology and molecular docking methods. Objective: To analyze the pharmacological mechanism of PCB in the treatment of skin aging to provide a reference for new drug development and clinical application. Methods: Active ingredients and related targets of PCB and skin aging-related disease targets are obtained through public databases, and the "drug-disease-target" and protein-protein interaction (PPI) network diagrams were constructed with the help of software to screen the core targets; then GO analysis and KEGG pathway analyses were performed on the target; finally, the molecular docking between the components and the targets were verified. Results: 112 intersection targets of active compounds of skin aging and PCB were obtained after the screening. GO, and KEGG enrichment analysis found that these biological processes mainly focus on epithelial cell proliferation, aging, growth factors, longevity regulation pathway, cancer pathway, AGE-RAGE signal pathway, PI3K Akt signal pathway and IL-17 signal pathway. The molecular docking results showed quercetin, apigenin, irisnepalensis isoflavone, 3,23-dihydroxy- 12-oleorene-28-oleic acid, 5-hydroxy-7,4'- dimethoxyflavone and other major compounds were connected with TP53, JUN, HSP90AAL, AKT1 and MAPK1 through hydrogen bonds, and there was high binding energy between them. Conclusion: Through multi-target prediction and molecular docking verification, it shows that PCB has a strong effect in the treatment of skin aging, which provides a reference for further research.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Molecular Medicine,General Medicine

Reference57 articles.

1. Tang P.P.; Bai M.; Miao M.S.; Traditional Chinese medicine research and network pharmacology. J Tradit Chin Med 2012,27(9),1112-1115

2. Azmi A.S.; Mohammad R.M.; Rectifying cancer drug discovery through network pharmacology. Future Med Chem 2014,6(5),529-539

3. Zheng R.; Chen Q.; Huang M.H.; Syndrome differentiation and treatment of severe acute respiratory syndrome coronavirus 2 infected pneumonia from “cold and dampness epidemic virus. Chin J Inform Trad Chin Med 2020,27(08),18-20

4. Huang F.S.; Xie K.M.; Ma Y.F.; Wu J.D.; Qi Y.Z.; Pan X.Y.; Wang S.L.; Lei Z.; Tao J.W.; Zhu H.J.; Chen Z.J.; Mechanism of Yuanhuzhitong decotin for osteoarthritis based on network pharmacology. JHainan Med Coll 2020,26(07),496-505

5. Anderson J.; Anderson Y.; Diyabalanage T.; Paving the way with actives for skincare. Planta Med 2015,81(11),IL23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3